Israel suspected that vaccine efficacy may be waning in early July. Made a decision to offer a booster dose for high risk people July 30. And to all adults August 29. Early call.

Data mow support that call. Let's look at boosters.

1/
Their early decision gave early data on boosters. The first data came within days.
2/
A follow up large real world study confirmed that a booster dose dramatically reduces risk of symptomatic infection.
3/
The complicating factor is vaccine equity and fairness, and the rise of mutant variants in unvaccinated parts of the world. But on the specific scientific question on whether a booster dose is effective, the evidence is very strong that it is.
6/
Which brings us to some interesting recurrent issues. From masks to vaccines various places have made early judgment calls that others later adopted. Many of us have also had different thresholds.

Some of us called for a booster early on for vulnerable populations.
7/
Recognizing that even with equity concerns we had doses expiring and going waste. So giving them to high risk patients could be considered.
8/
We see these type of early judgment calls ahead of the CDC now by various places: California, Colorado, New Mexico, New York City.

I don't think we should second guess these judgment calls made in the public interest. Data support them.
9/
google.com/amp/s/www.nyti…
The second issue is that it is fascinating to see how data evolves and how decisions are made. Some of the early data that a booster dose may be effective came quite early. In June.
10/
Data that it can help high risk populations came from a study in organ transplant patients.
11/
Most docs seemed to agree that a booster would help in early August. Well before the CDC decision for high risk patients that came Sept 24th.
12/
In face CDC experts thought the same even in July, but were reluctant to act.
13/
Its good to recognize just as there are risks in an early call, there are also risks in waiting for perfect data. These are also not easy judgment calls. There is a lot of analysis of data, pros and cons. For leaders, it's good to have deep thinkers and experts on the team.
*now

Sorry about the typo!
*fact
Some questions on why the first 2 doses were not enough.

Some thoughts. Durability of immunity is dependent on many factors:

1) antigen dose
2) the way in which the antigen is presented to the immune system
3) host factors: age, comorbidities
4) interval between exposures
New virus, new vaccines. We are constantly learning.

The first 2 doses continue to provide high degree of protection against severe disease. But because even mild breakthroughs can spread infection to vulnerable and unvaccinated populations, we have to try to get all cases down

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vincent Rajkumar

Vincent Rajkumar Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VincentRK

15 Nov
If you don't have immunity, the Covid virus poses a clear and present risk. Get immunity the safe way: Vaccines.
1/
If you already had COVID and think you are safe, don't take chances. Immunity is more durable and effective with another exposure to the same antigen. Basic immunology 101. Get your second exposure the safe way: Vaccines.
2/
If are already fully vaccinated, get a booster if it is offered for your age and risk group in your area. It's the safe way to strengthen immunity.
3/
Read 4 tweets
14 Nov
Minnesota now has the highest number of cases per capita in the country. Florida, the lowest. But don't rush to conclusions. Florida paid a price with a high loss of life in its recent wave, the highest since the start of vaccinations. #GetVaccinated
Vaccines are highly effective. Deaths are mainly in unvaccinated. health.state.mn.us/diseases/coron…
Breakthrough cases are occurring and people who are eligible need to get boosters. But once again, the vaccines are highly effective in preventing serious disease and deaths.
Read 6 tweets
13 Nov
If prescription drug prices are very high and keep rising, if you reduce out of pocket costs for patients, premiums go up; if you reduce premiums, out of pocket costs for patients go up.

That's the truth.
You cannot have a system that relies on the generosity of Pharma to keep prices affordable. They will keep increasing drug prices to meet targets as the law allows them to set the price and prevents Medicare from negotiating.

Lowering out of pocket costs is a band aid.
You cannot give monopoly protection for >10 years and have no way of negotiating either launch prices or price increases. Particularly when the product is life saving.
Read 7 tweets
12 Nov
Breaking: I am thrilled that Yelak Biru @NorthTxMSG has been appointed the CEO of the International Myeloma Foundation. @IMFmyeloma

Yelak is a visionary leader who will provide inspirational leadership in our pursuit to cure myeloma. @BrianDurieMD @jmikhaelmd Image
Susie Durie, who has led the organization for 31 years will assume the role of Founder and Director of Global Patient Initiatives.
Read 4 tweets
11 Nov
Singapore 85% vaccinated.

92,132 cases in last 28 days

98.7% mild symptoms or asymptomatic

0.7% needed oxygen
0.3 % ICU
0.2 % died

"Seniors 60 years old and above, especially if unvaccinated, continue to be more adversely affected by COVID-19."

channelnewsasia.com/singapore/covi…
As I look at these data, and what's going on in Europe, vaccinated younger people after vaccines and most elderly people are very well protected. But some elderly and immunocompromised may not mount a durable immune response after vaccines.
Boosters are therefore important for elderly and immunocompromised people. Early use of monoclonal antibodies are also important and should be used if available.
Read 4 tweets
3 Nov
Medicare Part D covers >3500 prescription drugs. Over 2400 of these are made by only one manufacturer (monopolies).

The prescription drug plan to let Medicare negotiate covers 10 drugs starting 2025. 20 drugs per year after.

Yet Pharma protests. Let's keep things in context.
New drugs are protected for 9 years from time on market from negotiation. Biologics for 12 years. Price increases capped to inflation.

Which means expect Pharma to "front load" prices. That means make the launch price much higher to cover all of this loss of revenue. @DavidP4AD
Out of pocket for seniors capped. Good. Important.

But it also means someone still pays Pharma. That's Medicare. Which is back to us, the public. So it's not like Pharma is losing money that way either.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(